Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage
- PMID: 7267032
- DOI: 10.1016/s0161-6420(81)34972-0
Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage
Abstract
This paper describes experience gained with 663 eyes of patients with diabetic vitreous hemorrhage treated by closed vitrectomy with a follow-up period of six months. Hemorrhages were nearly always associated with proliferative retinopathy (97%) and were thought to be caused always by ruptured proliferative vessels. Membrane removal was performed in 42% of all cases but in 60% when the retina was detached. The most common surgical complication was creation of retinal holes; more common when the posterior retina was detached (32%) than when it was attached (18%). The lens was removed in 73% of the cases. Eighty-two percent of the retained clear lenses remained clear at the six months follow-up period. Therefore, clear lenses should not be removed. Visual improvement could be achieved in 59% of the cases where the posterior retina was attached but only in 25% where it was detached resulting in an overall major visual improvement in 46% of the cases. If one adds to this group the cases that retained reasonable vision of 20/200 or better, the overall success rate was 51%. Posterior retinal detachment and rubeosis of the iris were the main factors for a bad prognosis. Forty-two percent of all eyes had at least some degree of rubeosis iridis. Most of the preoperative rubeotic eyes had rubeosis postoperatively (71%). Twenty-three percent of all eyes ended up with neovascular glaucoma.
Similar articles
-
Vitrectomy for complications of diabetic retinopathy.Arch Ophthalmol. 1978 Feb;96(2):237-46. doi: 10.1001/archopht.1978.03910050105001. Arch Ophthalmol. 1978. PMID: 629669
-
Pars plana vitrectomy for the management of sever diabetic retinopathy.Am J Ophthalmol. 1976 May;81(5):561-70. doi: 10.1016/0002-9394(76)90117-3. Am J Ophthalmol. 1976. PMID: 1275033
-
[Vitrectomy and subsequent photocoagulation in proliferative diabetic retinopathy with vitreous hemorrhage].Klin Monbl Augenheilkd. 1986 Jan;188(1):5-8. doi: 10.1055/s-2008-1050563. Klin Monbl Augenheilkd. 1986. PMID: 2421045 German.
-
[Vitrectomy via pars plana. A histological study and an analysis of clinical results (author's transl)].Wien Klin Wochenschr Suppl. 1980;108:1-22. Wien Klin Wochenschr Suppl. 1980. PMID: 6769257 Review. German.
-
Management of proliferative diabetic retinopathy.Compr Ophthalmol Update. 2007 Sep-Oct;8(5):245-56. Compr Ophthalmol Update. 2007. PMID: 18201511 Review.
Cited by
-
[Autologous serum versus hyaluronic acid eye drops for the treatment of corneal erosions after vitrectomy in diabetic patients. A prospective randomized study].Ophthalmologe. 2005 Sep;102(9):863-8. doi: 10.1007/s00347-005-1201-y. Ophthalmologe. 2005. PMID: 15821920 Clinical Trial. German.
-
Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.JAMA. 2020 Dec 15;324(23):2383-2395. doi: 10.1001/jama.2020.23027. JAMA. 2020. PMID: 33320223 Free PMC article. Clinical Trial.
-
Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus.Graefes Arch Clin Exp Ophthalmol. 1989;227(1):1-8. doi: 10.1007/BF02169815. Graefes Arch Clin Exp Ophthalmol. 1989. PMID: 2465937
-
Posterior chamber intraocular lens implantation during pars plana lensectomy and vitrectomy for diabetic complications.Graefes Arch Clin Exp Ophthalmol. 1989;227(2):136-8. doi: 10.1007/BF02169785. Graefes Arch Clin Exp Ophthalmol. 1989. PMID: 2721981
-
Diabetic retinopathy for the non-ophthalmologist.Clin Med (Lond). 2022 Mar;22(2):112-116. doi: 10.7861/clinmed.2021-0792. Clin Med (Lond). 2022. PMID: 35304370 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials